Immunotherapy for Uterine Cervical Cancer Using Checkpoint Inhibitors: Future Directions

Immune checkpoint inhibitors (ICIs) have demonstrated marked clinical effects worldwide, and “cancer immunotherapy” has been recognized as a feasible option for cancer treatment. Significant treatment responses have already been attained for malignant melanoma and lung cancer, ahead of gynecologic c...

Descripción completa

Detalles Bibliográficos
Autores principales: Kagabu, Masahiro, Nagasawa, Takayuki, Sato, Chie, Fukagawa, Yasuko, Kawamura, Hanae, Tomabechi, Hidetoshi, Takemoto, Shuji, Shoji, Tadahiro, Baba, Tsukasa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7177858/
https://www.ncbi.nlm.nih.gov/pubmed/32230938
http://dx.doi.org/10.3390/ijms21072335

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7177858/
https://www.ncbi.nlm.nih.gov/pubmed/32230938
http://dx.doi.org/10.3390/ijms21072335

Ejemplares similares